SAFETY AND PHARMACOKINETICS
Clinical trials for SAFETY AND PHARMACOKINETICS explained in plain language.
Never miss a new study
Get alerted when new SAFETY AND PHARMACOKINETICS trials appear
Sign up with your email to follow new studies for SAFETY AND PHARMACOKINETICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could shorter antibiotic courses be safer for preterm babies?
Disease control Not yet recruitingThis study looks at whether preterm infants in the NICU who are started on ampicillin for possible early-onset sepsis can safely stop the antibiotic after 24 to 36 hours instead of the usual 48 hours. Researchers will measure ampicillin levels in the blood and monitor the babies …
Matched conditions: SAFETY AND PHARMACOKINETICS
Phase: PHASE1, PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New drug safety check: healthy volunteers test fluorothiazinone
Knowledge-focused Not yet recruitingThis early-stage study checks if a new drug, Fluorothiazinone, is safe for people and how the body processes it. It involves 70 healthy adults aged 18 to 45. Participants receive either the drug or a placebo, and doctors monitor for side effects. No treatment for any disease is b…
Matched conditions: SAFETY AND PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC